icotec launched the brand name of BlackArmor® for its Carbon/PEEK material, which has been used in spinal and fracture repair devices for 15 years in 20,000 implantations.Â
AxioMed received approval from the Therapeutic Goods Administration to market cervical and lumbar Freedom Viscoelastic Disc Replacement devices in Australia.
Amendia launched the Syzygyâ„¢ Stabilization System, intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion.Â
Study results support the biocompatibility of Rotation Medical’s collagen-based bioinductive implant and its ability to promote new connective tissue with the appearance of tendon.
Spineology launched a range of TLIF technologies for use with the Anatomy-Conserving Medial Lumbar Interbody Fusion platform (ACT MediaLIF™). These technologies support TLIF placement of interbody devices using a direct posterior approach.
Regentis Biomaterials received FDAÂ Investigational Device Exemption approval to initiate a pivotal Phase III clinical study of its GelrinC procedure to treat focal knee cartilage defects.